Hot Stocks: BA jumps on Dreamliner news, HSBC gains on earnings, PSO also rises 10%, while IPHA sinks
alzay

At the start of August, Boeing (NYSE:BA) shares have climbed higher after the company cleared FAA obstacles for resuming 787 Dreamliner deliveries. Also trending to the topside is HSBC Holdings plc (NYSE:HSBC) and Pearson plc (NYSE:PSO). HSBC is up on Q2 earnings while PSO has risen on 1H22 revenue and EPS growth.
At the other end of the spectrum Innate Pharma S.A. (NASDAQ:IPHA) are down more than 10%.
Gainers
Shares of Boeing (BA) moved up on Monday morning by 4.7% after the Federal Aviation Administration has approved the companyâs plan aimed at addressing problems with the 787 Dreamliner. BA announced that it had 120 undelivered Dreamlinerâs, which analysts estimate are worth more than $25B in its inventory.
HSBC Holdings plc (HSBC) tracked higher in premarket trading, up 8.2%. Shares of the financial stock are in the green after a strong Q2 earnings report. HSBC reported a Q2 profit after tax of $5.8B, which includes a $1.8B deferred tax gain. Moreover, the firmâs revenue was recorded at $13.1B (+12% Y/Y).
Pearson plc (PSO) popped 10% after the British publishing and education organization reported high 1H22 revenue and EPS growth. PSO provided investors with 1H EPS of 22.5p compared to 10.5p in prior year period. Revenue's were Â£1.79B (+11.9% Y/Y).
Decliner
Innate Pharma S.A. (IPHA) sunk 15.9% after the company said a phase 3 trial of monalizumab to treat a type of head and neck cancer was being discontinued by AstraZeneca (AZN) as the drug failed to show the desired efficacy.
For more of Wall Streetâs best- and worst-performing stocks on the trading day, click over to Seeking Alpha's On The Move section.